Hepatitis B Virus Core Protein (147-183), Human HBc147-183

General Information


DRACP ID  DRACP03638

Peptide Name   Hepatitis B Virus Core Protein (147-183), Human HBc147-183

Sequence  TVVRRRGRSPRRRTPSPRRRRSQSPRRRRSQSRESQC

Sequence Length  37

UniProt ID  G9G8L1 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C180H328N88O52S

Absent amino acids  ADFHIKLMNWY

Common amino acids  R

Mass  523140

Pl  13.14

Basic residues  16

Acidic residues  1

Hydrophobic residues  2

Net charge  15

Boman Index  -28079

Hydrophobicity  -240.27

Aliphatic Index  15.68

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  11

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 27241023

Title  Improvement of in vivo antimicrobial activity of HBcARD peptides by D-arginine replacement

Doi Not available

Year  2016

Literature 2

Pubmed ID 23785287

Title  Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD)

Doi Not available

Year  2013

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  9344

DRACP is developed by Dr.Zheng's team.